---
theme: academic
layout: cover
class: text-white
coverAuthor: beau hilton
coverAuthorUrl: https://www.beauhilton.com
coverDate: "2024-03-22"
themeConfig:
  paginationX: r
  paginationY: t
  paginationPagesDisabled: [1]
title: Cold Agglutinin Disease
info: |
  # Cold Agglutinin Disease
  Case Conference 2024-03-22, [Beau Hilton](https://www.beauhilton.com)

---

# Cold Agglutinin Disease

---

# Copyable things

<v-clicks>

</v-clicks>

Footnotable.<sup>1</sup>

<Footnotes separator>
  <Footnote :number=1><a href="https://beauhilton.com" rel="noreferror" target="_blank">Footnote</a></Footnote>
</Footnotes>

---

# Case presentation

72F, p/w hgb 3.8. A little tired.

<v-clicks>

Some discoloration of fingers, she says it's worse (and painful) when it's cold.

No notable icterus.

Elevated indirect bili. LDH elevated.

Hapto undetectable.

Retic elevated.

+RBC clumping on smear. Other cells normal in morphology and number.

DAT: IgG weakly +, C3+

</v-clicks>

---

# Confirming the diagnosis

<v-clicks>

- flow cytometry
- SPEP, SFLC (usu IgM kappa)
- maximal thermal amplitude (>28C)
- cold-temperature titre (>=64)
- BMBx (sometimes)

</v-clicks>

---

# Differential diagnosis

<v-clicks>

- CD5- (>50% CAD -ve for CD5), CD10- B cells: MZL vs LPL (Waldenstrom)
- no extramedullary disease (may push you toward MZL)
- no B symptoms (may be difficult to separate from infx)
- MYD88 L265P -ve (usu + in LPL)
- certain clusters of genomic and cytogenetic changes, e.g. KMT2D variant (69%) complete or partial gain of chromosome 3 (93%)
- WHO 2022: CAD is now a distinct lymphoid neoplasm (hopefully, more diagnostic consensus will follow)

</v-clicks>

---

# Case presentation

<v-clicks>

- 2010: p/w hemolytic anemia, eventually found to have cold agglutinin disease
- 2010 - 2015: rituximab, multiple cycles
- 2016: rituximab + fludarabine
- 2018: rituximab + bortezomib
- 2019: rituximab + bendamustine
- 2022: sutimlimab recommended

</v-clicks>

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/de-urinis.png
---

# A jaunt through history

## 1200s

Johannes Actuarius, Constantinople court physician, publishes *De Urinis*, which notes: "Yea indeed an extremely black urine... signifies extreme chilliness."

<v-clicks>

(syphilis causes paroxysmal cold hemoglobinuria, so used to be much more common)

(but watch out for a resurgence - syphilis cases went up 80%, to 207,000 in 2022)

</v-clicks>

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/poor-pup.png
---

# A jaunt through history

## 1800s

Trypanosomiasis (N'gana, sleeping sickness) is found to cause deep anemias, partially via hemolysis.

https://vetclinpathimages.com/2018/04/27/trypanosoma/

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/trypanosomes-bovine.jpg
---

# A jaunt through history

## 1898

Mssrs. Kanthack, Durham, and Blandford describe agglutination
in red blood cells of animals infected with trypanosomes.

"Instead of forming rouleaux,
the red corpuscles tend to clump into masses and to lose their outlines,
especially when the anaemia is pronounced (rabbit, ass, and horse).
The serum of such blood, when mixed with normal blood of the same species of animal,
causes the red corpuscles to clump together also."

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/karl.jpg
---

# A jaunt through history

## 1903

Karl Landsteiner publishes "About Relationships Between the Blood Serum and the Body Cells"
(*Über Beziehungen zwischen dem Blutserum und den Körperzellen*),
which contains a description of blood agglutination at cold temperatures (thermal amplitude 0-5C).

He's the guy who discovered blood types,
under the term "iso-agglutination,"
and won the Nobel Prize in Medicine for this in 1930.

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/mycoplasma.jpg
---

# A jaunt through history

## 1918

Clough and Richter publish "A study of an autoagglutinin occurring in a human serum,"
first definite cases of cold agglutination in humans,
describing the relationship between agglutination, hemolysis, and pneumonia.

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/churchill.jpg
---

# A jaunt through history


## 1937

McCombs and McElroy note that the huge increase in surgical transfusions
since Landsteiner's discovery has revealed a number of cases of cold agglutination
found in the blood bank (thermal amplitude 0-25 C), confusing technicians nation-wide.

(And occasionally leading to death)

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/coat.png
---

# A jaunt through history


## 1946

Lubinski and Goldbloom collect and describe 7 cases of cold agglutination with a thermal amplitude of 0-37C,
all associated with hemolytic anemia (5 primary cases, 1 sepsis, 1 syphilis).

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/electro.png
---

# A jaunt through history


## 1957

Christenson et al perform the first isolation of a monoclonal protein, a cold agglutinin.
One of the pts also has a cryoglobulin.

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/olesen.png
---

# A jaunt through history


## 1964

Olesen publishes the first paper with a successful drug treatment for CAD,
choosing chlorambucil based on the then-recent success of this drug in Waldenstrom macroglobulinemia.
Follow-up in 1970 with 4 pts has similar results.

(One pt got cyclophosphamide for 4mo, switched to chlorambucil later on d/t drAE).

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/olesen.png
---

# A jaunt through history


## 1997

Rituximab comes to market.

## 1998

Lee and Kueck try rituximab (375 x4) in a pt w CAD, and it works.

## 2001

Berentsen et al report on a small prospective ritux study: 1 CR, 3 PR, 2 no response.

## 2006, 2013

Berentsen et al retrospectively report on a retrospective study: ritux-based regimens RR 67-83%.

## 2017

Berentsen et all, prospective study using BR: 71% RR, 40% CR, 31% PR. 50% RR in the retreatment setting. TTR 2mo. 77% response rate at 5y. Median DOR >88mo.

## 2018

Rossi et al report on 2L bortezomib (GIMEMA) (single cycle): 32% RR, median DOR 16mo.

## 2020, 2021

Case reports on CAS d/t pembro (Atiq 2020) and atezo (Acikgoz 2021).

## 2021

Roth et al report on sutimlimab monotherapy (CARDINAL),

## 2022

Roth et al report on sutimlimab monotherapy (CADENZA),

---

# Questions

How.<sup>1</sup>

<Footnotes separator>
  <Footnote :number=1><a href="https://beauhilton.com">Footnote</a></Footnote>
</Footnotes>

---
layout: figure-side
figureFootnoteNumber: 1
figureUrl: http://placekitten.com/200/300
---


# Epidemiology

<v-clicks>

- errbody got it

</v-clicks>


<Footnotes separator>
  <Footnote :number=1><a href="https://beauhilton.com">Footnote</a></Footnote>
</Footnotes>

---

# Prognosis

<v-clicks>

## heyo <sup>1</sup>

- yup <sup>2</sup>

</v-clicks>

<Footnotes separator>
  <Footnote :number=1><a href="https://doi.org/10.1210/jc.2018-01968">link</a></Footnote>
  <Footnote :number=2><a href="https://doi.org/10.3803%2FEnM.2020.35.1.157">link</a></Footnote>
</Footnotes>

---

# Management

---
layout: index
indexEntries:
  - { title: "HemOnc.org entry", uri: "https://hemonc.org" }
  - { title: "NCCN Guidelines", uri: "https://www.nccn.org/professionals/physician_gls" }
  - { title: "PathologyOutline", uri: "https://www.pathologyoutlines.com" }
  - { title: "", uri: "" }
indexRedirectType: external
---

# Resources

---

# Bibliography

Use HTML export from Zotero.
It's great.

- R-click on the collection name (or highlight all the citations you want)
- "Create Bibliography from Collection" (APA is pretty good, doesn't include numbering [which is good], does include hyperlinks)
- Output Mode: Bibliography
- Output Method: Save as HTML
- copy all the div/span cites and replace the inner stuff below

Looks kinda like the following
(note I changed the text size with `text-sm` from WindiCSS):

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Al Subhi, Abdul Rahman, Veronica Boyle, and Marianne S. Elston. “Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years.” <i>Journal of the Endocrine Society</i> 6, no. 9 (September 1, 2022): bvac105. <a href="https://doi.org/10.1210/jendso/bvac105">https://doi.org/10.1210/jendso/bvac105</a>.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1210%2Fjendso%2Fbvac105&amp;rft_id=info%3Apmid%2F35919261&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Systematic%20Review%3A%20Incidence%20of%20Pheochromocytoma%20and%20Paraganglioma%20Over%2070%20Years&amp;rft.jtitle=Journal%20of%20the%20Endocrine%20Society&amp;rft.stitle=J%20Endocr%20Soc&amp;rft.volume=6&amp;rft.issue=9&amp;rft.aufirst=Abdul%20Rahman&amp;rft.aulast=Al%20Subhi&amp;rft.au=Abdul%20Rahman%20Al%20Subhi&amp;rft.au=Veronica%20Boyle&amp;rft.au=Marianne%20S.%20Elston&amp;rft.date=2022-09-01&amp;rft.pages=bvac105&amp;rft.issn=2472-1972&amp;rft.language=eng"></span>

</div>
